Success Metrics

Clinical Success Rate
50.0%

Based on 1 completed trials

Completion Rate
50%(1/2)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
1(33%)

Phase Distribution

Ph not_applicable
2
67%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution2 total trials
N/ANon-phased studies
2(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

50.0%

1 of 2 finished

Non-Completion Rate

50.0%

1 ended early

Currently Active

0

trials recruiting

Total Trials

3

all time

Status Distribution
Completed(1)
Terminated(1)
Other(1)

Detailed Status

Completed1
unknown1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
0
Success Rate
50.0%
Most Advanced
N/A

Trials by Phase

N/A2 (100.0%)

Trials by Status

completed133%
unknown133%
terminated133%

Recent Activity

0 active trials
Showing 3 of 3
terminated

Description of the Evolution of Functional Dysphonia Managed by Hypnotherapy

NCT05179811
unknownnot_applicable

Demonstrate the Value of Using Hypnosis in Chimiotherapy- Induced Chronic Neuropathies

NCT03156595
completednot_applicable

Randomized Controlled Study of the Efficacy of Hypnosis Versus Relaxation and Control in Neuropathic Pain

NCT02256371

Clinical Trials (3)

Showing 3 of 3 trials
NCT05179811

Description of the Evolution of Functional Dysphonia Managed by Hypnotherapy

Terminated
NCT03156595Not Applicable

Demonstrate the Value of Using Hypnosis in Chimiotherapy- Induced Chronic Neuropathies

Unknown
NCT02256371Not Applicable

Randomized Controlled Study of the Efficacy of Hypnosis Versus Relaxation and Control in Neuropathic Pain

Completed

All 3 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
3